Pediatric leadership silence on FDA ADHD recall

“The FDA has issued a nationwide recall of lisdexamfetamine capsules.” That sentence in Newsweek magazine should have triggered alerts, guidance, and coordinated response. Instead, the silence from pediatric leadership has been deafening. Newsweek turned to the FDA and the American Academy of Family Physicians. Where are the leadership of the American Academy of Pediatrics (AAP)

Read more…

Pediatric leadership silence on FDA ADHD recall originally appeared in KevinMD.com.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.